HOUSTON, May 29, 2025 /PRNewswire/ -- Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today ...

Cytotoxic function of human natural killer cells is transiently inhibited by transforming growth factor beta (TGFβ). This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...

A new study suggest that using CXCL9 and CXCL10-producing dendritic cells alongside immunotherapy can be a promising strategy to overcome treatment resistance and improve clinical outcomes for ...

Dendritic cells (DCs) are exceptionally potent antigen-presenting cells (APCs) in the human body and are considered the “sentinels” of the immune system. They are essential in establishing, ...

A powerful approach to cancer therapy involves modifying the patient’s own immune cells in order to enhance the immune response against cancer cells. The most studied cell types for cancer ...

Researchers from the Institute of Human Virology (IHV) at the University of Maryland School of Medicine have discovered how a ...